ArticleBMJ open2026
Prevalence of hearing loss across age groups in Nepal: a systematic review and meta-analysis protocol.
Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionHearing loss is a global health problem. It is not only an impairment of hearing but also has debilitating effects on the social, emotional and cognitive domains. It also imposes costs on a country's healthcare sector, which must first be identified to prevent the prevalence of the impairment. In a low- and middle-income country like Nepal, there is no published systematic review on the prevalence of hearing loss. We aim to perform a systematic review and meta-analysis on the national prevalence of hearing loss in Nepal across all age groups. METHODS AND ANALYSIS: We will report our findings in line with the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols guidelines. We will search the MEDLINE (PubMed) and Nepal Journals Online databases for publications in Nepali and English. Google Scholar will also be used to broaden the search scope. We will also search grey literature, like government reports. Studies that report the prevalence of hearing loss in Nepal will be included. Titles and abstracts of the studies will be independently screened by both reviewers (PB and SA) using Rayyan software. Full-text articles that pass the initial screening will also be independently reviewed by both reviewers. Disagreements will be resolved through discussion at all stages. If necessary, a third reviewer will be invited, and the original author will be contacted where appropriate (e.g., when data are missing in the original study). We will perform a narrative synthesis of the study results. Cochran's Q test and the I² statistic will be calculated to assess heterogeneity. I² values of 25%, 50% and 75% will be interpreted as indicating low, moderate and high heterogeneity, respectively. We will conduct a meta-analysis using a random-effects model, which accounts for both within-study and between-study variability. We will perform a sensitivity analysis to examine whether a single study disproportionately contributes to heterogeneity. Potential publication bias will be evaluated using both visual and statistical approaches (Funnel plot and Egger's test). In addition, if funnel plot asymmetry is observed, trim-and-fill analysis will be conducted. Statistical tests will be performed in R (V.4.3.1) using RStudio (V.2023.06.1+524) with the metafor package for meta-analysis. ETHICS AND DISSEMINATION: Ethics approval is not required for this protocol. This review and meta-analysis are based entirely on secondary data; no primary data will be collected. Our findings will be useful to quantify the national prevalence of hearing impairment in Nepal. They may be useful for developing intervention policies and furthering research agendas for government agencies and hearing-health researchers alike. The results will be presented at conferences, published in peer-reviewed journals and shared with relevant policy-making bodies. PROSPERO REGISTRATION NUMBER: CRD420251120903.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.